CAROLINE MEYER: Open Payments
NPI 1992247910 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 14 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $488 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| ABBVIE INC. | 4 | $97 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $15 |
Products named: LEQVIO, REXULTI, UBRELVY, QULIPTA, BOTOX, ONPATTRO, CLEVIPREX.
Industry payments across KY — which companies pay providers there.
